The problem of doping and current doping list;Dopingproblematik und aktuelle dopingliste

Deutsche Zeitschrift fur Sportmedizin

Volumn 55, Issue 4, 2004, Pages 90-95

  Kindermann, W ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Doping list; Performance enhancing effect; Scientific findings

Indexed keywords

EID: 25144453745     PISSN: 03445925     EISSN: 03445925     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Balsom PD, Söderlund K, Ekblom B: Creatine in humans with special reference to creatine supplementation. Sports Med 18 (1994) 268-280.
2. Bedi JF, Gong H, Horvath SM: Enhancement of exercise performance with inhaled albuterol. Can J Sport Sci 13 (1988) 144-148.
3. Bell DG, Jacobs I, Ellerington K: Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc 33 (2001) 1399-1403.
4. Bell DG, Jacobs I, Zamencnik J: Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise. Eur J Appl Physiol 77 (1998) 427-433.
5. Bell DG, McClellan TM, Sabiston CM: Effect of ingesting caffeine and ephedrine on 10-km run performance. Med Sci Sports Exerc 34 (2002) 344-349.
6. Bidlingmaier M, Wu Z, Strasburger CJ: Problems with GH doping in sports. J Endocrinol Invest 26 (2003) 924-931.
7. Bouchard R, Weber AR, Geiger JD: Informed decision - making on sympathomimetic use in sport and health. Clin J Sport Med 12 (2002) 209-224.
8. Campos DR, Yonamine M, de Moraes Moreau RL: Marijuana as doping in sports. Sports Med 33 (2003) 395-399.
9. Carlsen KH, Ingjer F, Kirkegaard H, Thyness B: The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes. Scand J Med Sci Sports 7 (1997) 160-165.
10. Chandler JV, Blair SN: The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc 12 (1980) 65-69.
11. Collomp K, Candau R, Lasne F, Labsy Z, Prefaut C, De Ceaurriz J: Effects of short-term oral salbutamol administration on exercise endurance and metabolism. J Appl Physiol 89 (2000) 430-436.
12. Dean H: Does exogenous growth hormone improve athletic performance? Clin J Sport Med 12 (2002) 250-253.
13. Evans NA: Current concepts in anabolic-androgenic steroids. Am J Sports Med 32 (2004) 534-542.
14. Fleck SJ, Lucia A, Storms WW, Wallach JM, Vint PF, Zimmerman SD: Effects of acute inhalation of albuterol on submaximal and maximal VO2 and blood lactate. Int J Sports Med 14 (1993) 239-243.
15. Gillies H, Derman WE, Noakes TD, Smith P, Evans A, Gabriels G: Pseudoephedrine is without ergogenic effects during prolonged exercise: J Appl Physiol 81 (1996) 2611-2617.
16. Graham TE: Caffeine, coffee and ephedrine: impact on exercise performance and metabolism. Can J Appl Physiol 26 (2001) S103-S119.
17. Graham TE: Caffeine and exercise: metabolism, endurance and performance. Sports Med 31 (2001) 785-807.
18. Jenkins PJ: Growth hormone and exercise: physiology, use and abuse. Growth Horm IGF Res 11 (2001) S71-S77.
19. Juhn MS, Tarnopolsky M: Potential side effects of oral creatine supplementation: a critical review. Clin J Sport Med 8 (1998) 298-304.
20. Kovacs EM, Stegen JHCH, Brouns F: Effect of caffeinated drinks on substrate metabolism, caffeine excretion, and performance. J Appl Physiol 85 (1998) 709-715.
21. Larsson K, Gavhed D, Larsson L, Holmer L, Jorfelt L, Ohlsen P: Influence of a beta2-agonist on physical performance at low temperature in elite athletes. Med Sci Sports Exerc 29 (1997) 1631-1636.
22. Larsson K, Ohlsen P, Larsson L, Malmberg P, Ryddtrom PO, Ulriksen H: High prevalence of asthma in cross country skiers. Br Med J 307 (1993) 1326-1329.
23. Lasne F, De Ceaurriz J: Recombinant erythropoietin in urine. Nature 405 (2000) 635.
24. Maiolo C, Fuso L, Todaro A, Anatra F, Boniello V, Basso S, DeLorenzo A, Pistelli R: Prevalence of asthma and atopy in italian olympic athletes. Int J Sports Med 25 (2004) 139-144.
25. Martineau L, Horan MA, Rothwell NJ, Little RA: Salbutamol, a beta-2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci 83 (1992) 615-621.
26. McKenzie DC, Rhodes EC, Stirling DR, Wiley JP, Dunwoody DW, Filsinger IB, Jang F, Stevens A: Salbutamol and treadmill performance in non-atopic athletes. Med Sci Sports Exerc 15 (1983) 520-522.
27. Meeuwisse WH, McKenzie DC, Hopkins SR, Road JD: The effect of salbutamol on performance in elite nonasthmatic athletes. Med Sci Sports Exerc 24 (1992) 1161-1166.
28. Morton AR, Joyce K, Papalia SM, Carroll NG, Fitch KD: Is salmeterol ergogenic? Clin J Sport Med 6 (1996) 220-225.
29. Morton AR, Papalia SM, Fitch KD: Changes in anaerobic power and strength performance after inhalation of salbutamol in nonasthmatic athletes. Clin J Sport Med 3 (1993) 14-19.
30. Norris SR, Petersen SR, Jones RL: The effect of salbutamol on performance in endurance cyclists. Eur J Appl Physiol 73 (1996) 364-368.
31. Sandsund M, Sue-Chu M, Helgerud J, Reinertsen RE, Bjermer L: Effect of cold exposure and salbutamol treatment on physical performance in elite nonasthmatic cross-country skiers. Eur J Appl Physiol 77 (1998) 297-304.
32. Signorile JF, Kaplan TA, Applegate B, Perry AC: Effects of acute inhalation of the bronchodilator, albuterol, on power output. Med Sci Sports Exerc 24 (1992) 638-642.
33. Silver MD: Use of ergogenic aids by athletes. J Am Acad Orthop Surg 9 (2001) 61-70.
34. Smith C, Beecher H: Amphetamine sulfate and athletic performance. JAMA 170 (1959) 542-557.
35. Soetens E; DeMeirleir K, Hueting J: No influence of ACTH on maximal performance. Psychopharmacology 118 (1995) 260-266.
36. Stewart IB, Labreche JM, McKenzie DC: Formoterol and performance in elite non-asthmatic athletes. Med Sci Sports Exerc 34 (2002) 213-217.
37. Stewart IB, Labreche JM, McKenzie DC: Effect of a long- and short-acting beta-2-agonist on exercise-induced arterial hypoxemia. Med Sci Sports Exerc 35 (2003) 603-607.
38. Sue-Chu M, Sandsund M, Helgerud J, Reinertsen R, Bjermer L: Salmeterol and physical performance at -15 degrees C in highly trained nonasthmatic cross-country skiers. Scand J Med Sci Sports 9 (1999) 48-52.
39. Swain RA, Harsha DM, Baenziger J, Saywell RM: Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion? Clin J Sports Med 7 (1997) 168-173.
40. Walker DJ, Zacny JP: Subjective, psychomotor and physiologic effects of cumulative doses of opioid agonists in healthy volunteers. J Pharmacol Exp Ther 289 (1999) 1454-1464.
41. Wilber RL: Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid. Sports Med 32 (2002) 125-142.
42. World Anti-Doping Agency (WADA): The 2004 Prohibited List. www.nada-bonn.de
43. Wyndham CH, Rogers GG, Benade AJ, Strydom NB: Physiological effects of the amphetamines during exercise. S Afr Med J 45 (1971) 247-252.